Alzheimer's disease trials recruiting in Rhode Island

All Alzheimer's disease trials nationally

Cities in Rhode Island

Recruiting trials in Rhode Island

• A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
  NCT05552157 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Rhode Island: Providence
• A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
  NCT07169578 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female) · Rhode Island: Providence
• A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
  NCT06647498 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Rhode Island: Providence
• A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
  NCT06585787 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Rhode Island: Providence
• A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
  NCT06976216 · Phase: Phase 3 · Ages: 60 Years to 85 Years · Sex: All (male and female) · Rhode Island: East Providence
• Alzheimer's Tau Platform: Master Protocol
  NCT06957418 · Phase: Phase 2 · Ages: 50 Years to 80 Years · Sex: All (male and female) · Rhode Island: Providence
• Clinical Trial on Agitation in Alzheimer's Dementia
  NCT05543681 · Phase: Phase 2 · Ages: 60 Years and older · Sex: All (male and female) · Rhode Island: Providence
• Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
  NCT06584357 · Phase: Not specified · Ages: 60 Years to 90 Years · Sex: All (male and female) · Rhode Island: East Providence
• Dominantly Inherited Alzheimer Network (DIAN)
  NCT00869817 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Rhode Island: Providence
• Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
  NCT05980949 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Rhode Island: Providence
• Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
  NCT04500847 · Phase: Phase 1 · Ages: 50 Years to 85 Years · Sex: All (male and female) · Rhode Island: Providence
• Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
  NCT07177352 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female) · Rhode Island: Providence